Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Janković, Jelena | Paskaš, Svetlana | Marečko, Ilona | Božić, Vesna | Cvejić, Dubravka | Savin, Svetlana
Affiliations: Institute for the Application of Nuclear Energy – INEP, Department for Endocrinology and Immunoradiology, University of Belgrade, Belgrade, Serbia | Clinical Center of Serbia, Department of Endocrine and Cardiovascular Pathology, Belgrade, Serbia
Note: [] Corresponding author: Svetlana Savin, Institute for the Application of Nuclear Energy – INEP, Department for Endocrinology and Immunoradiology, University of Belgrade, Banatska 31b, P.O.Box 46, 11080 Zemun – Belgrade, Serbia. Tel.: +381 11 2618 666; Fax: +381 11 2618 724; E-mail: ssavin@inep.co.rs
Abstract: We evaluated caveolin-1 expression in the human thyroid neoplasia spectrum with the aim of examining differences in expression as detected by two anti-caveolin-1 antibodies, and secondly, to investigate the association of caveolin-1 expression levels with aggressive papillary thyroid carcinoma (PTC). Immunohistochemical staining using sc894 or AV09019 antibodies revealed that caveolin-1 was generally overexpressed in the PTC group as a whole (classical and follicular variant) when compared to peritumoral tissue (PT), while it was not detected in about half of follicular thyroid carcinoma (FTC) and majority of follicular adenomas (FTA). Caveolin-1 expression decreased in the following order: clPTC, fvPTC, FTC, PT and FTA. The diagnostic accuracy of AV09019 was better than that of sc894 for discriminating: FTA from FTC, FTA or FTC from the follicular variant of PTC, total PTC from nonmalignant tissue, and malignant tumors from nonmalignant tissue. Spearman's analysis revealed positive correlations of caveolin-1 expression and extrathyroidal invasion (p< 0.05) in PTC for both antibodies. Additionally, AV09019 antibody correlated caveolin-1 upregulation with pathological T status. To conclude, as an immunohistochemical marker AV09019 antibody performed better than sc894 in distinguishing certain histotypes of thyroid tumors. In addition, increased expression of caveolin-1 may be considered as an indicator of papillary carcinoma progression.
Keywords: Thyroid tumors, caveolin-1, sc894 (Santa Cruz Biotechnology) antibody, AV09019 (Sigma-Aldrich) antibody, immunohistochemistry
DOI: 10.3233/DMA-2012-00934
Journal: Disease Markers, vol. 33, no. 6, pp. 321-331, 2012
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl